tag:blogger.com,1999:blog-1562387750337311798Fri, 24 Feb 2012 06:44:03 +0000Ethics PoliciesPoison PillsCNS SpectrumsMassachusetts gift banMedical Meetings MagazineOregonSmithKline BeechamCECentralSolvayLighthouse LearningKulongoskiJanssenAmerican Board of Medical SpecialtiesThe Carlat Medical ReportWilensPolicy and MedicineLizbeth KowalszykMacy FoundationvilazodoneProfessional Medical AssociationsgreedDowden Health MediaThackerDeval PatrickViibrydCME ZoneColbertFrontlineCenter for Medicine in the Public InterestCMEkey opinion leadersprescription data-miningPaul ThackerHormone replacement therapyAlan SchatzbergUniversity DiariesBremmerMedical SocietiesMassachusetts General Hospitalhired gunpsychologistsThe Infinite MindLatudaMcAllenAlison Basspromotional speakersGlaxoSmithKlineDollars for DocsIndianapolis StarMerckpodcastPV UpdatesJeffrey FlierFree samplesDSM-VWilliam CarpenterAnxiety disordersWashington PostJohns HopkinsDrug-drug interactionsClawsenDave DaviesMed Page TodaySymbyaxGovernor Deval PatrickBritish Medical JournalForest LaboratoriesFresh airchild psychiatryEffexorBMJPhysician paymentsObamadrug repsMelody PetersonRoyal College of PhysiciansManhattan ResearchMcGeeneyCVS CaremarkDuBuskeIn Her WakeSomaxonCephalondata-miningAntidoteSpielmansOff-label promotionInstitute for Continuing HealthcareBristol-Myers SquibbSchering-PloughGardiner Harrisi3 CMEJazz PharmaceuticalsghostwritingBoston GlobePhysician Payments Sunshine ActAstra Zenecapharma marketing blogAmerican Medical AssociationCarlat CME InstituteFunctional neuroimagingsuper PACsAARPStoweDirect to consumer adsBilly Rubin's BlogCEJAKickbacksBBCFurious SeasonsOregon Academy of Family PhysiciansVyvanseMina DulcanSunovionRobert FreedmanHealth care reformSchwitzerDr. RWJAMABiomarkersTim KukloCAFE studyPhRMA codeStephen Stahlpractice guidelines committeeNeuroscience education insttitutedrug companiesACCMECoalition for Healthcare CommunicationMilwaukee Journal SentinelCurrent PsychiatryDallas Leipzig International Valve 2010continuing medical educationJohn RussellEli LillyConflicts of InterestRadio BostonContraveRelmandepressionpsychotherapyDepression CentralAmerican Society of HypertensionJohnson and JohnsonRobert DeLeoCaliffHeart Rhythm SocietyPfizerFugh-BermanPhysiAppelbaumWired magazineindustry-free CMEPaul SimonWebMDConnorsNiravamCS2dayM/C CommunicationsVioxxVermontSPECTbipolar disorderSeroquelMcCainNew York Times MagazineGreater BostonChicago TribuneGreat BritainBoston UniversityPristiqOn PointBernard CarrollHealth Care RenewalBrand(x)Senate Finance CommitteeBehrmanseeding trialsRozeremMukherjeegift banLisa CosgrovePatent ExtendersPrescription projectMarketing tacticsAndrew WilnerAplenzinHarvard Medical SchoolPharmed OutStanford UniversityShahram AhariZimmermanNational Physician's AlliancePri-MedFauberShireSepracorBloggingCymbaltaMother JonesCerveroPain TVindustry-funded CMEgenericsLexaproOrexigenMichael FirstAmerican College of CardiologyVox MedicaGoodwinSilenorPrimedia HealthcareAndroGelJohn KelsoeLetters and ScienceNew HampshireUniversity of WisconsinAnatomy of an EpidemicSenator Herb KohlBlueSparkPRMSPsynomicsParryFDAMarcia AngellLiebowitzAMAADHDLuvox CRLLCCME ReformQuantiaMDTom SullivanGoldbergAngellMcMahon Publishing GroupPharmaceutical marketingtestosteroneHealthGradesDeVanegeneticsCME LLCTuftsMartin SamuelsAPAPlacebo Journal BlogAmen Clinicslegal consultationAlliance for CMEiPhoneThe Psychiatrist's ProgramMeghna ChakrabartiMental Health AmericanSAPHRISantipsychoticsCME Rogue's GalleryGooznerThought BroadcastAmerican Academy of Orthopaedic SurgeonsInstitute of MedicineJudith GrahamAPA electionsanofi aventisDoug BremnerCorruptionPremprobifeprunoxSteve DiFillippoCanadian Medical Associationprescriptive privilegesHealth AffairsWhitakerSchwarz PharmaEMSAMOtsukaDr. Drug RepVermont Psychiatric AssociationWoodbipolar depressionAsthma and ImmunologyCME OutfittersMinh UongCounter-detailingZyprexaSteven StahlJoseph BiedermanCME Peer ReviewPlacebo controlled trialReed ElsevierDavid PollyIMSIvan GoldbergpremarinTakedaRidge DiagnosticsThomas SullivanComparative effectiveness researchdisclosureAmerican Psychiatric AssociationGawandeGrassleyAbilifyneuroscienceCMETamar HosanskyPhysician disclosureAlzheimer's diseaseACCME reportSchatzbergMedscapeCommercial Support Free CMEAdvertisingNeuroinvestmentCommercial Bias InventoryInselBrigham and Woman's HospitalDavid KupferRemissionNovartisAllen FrancesBIO 2008Unbranded DoctorCarl ElliottMedbribeWilliam HeiselChantixDelaware Media GroupLuvox SRNatasha SingerViraceptDonna NorrisOranskyPathophiliaAmerican Academy of AllergyACREDesignWritedirty thirtyAntidepressantsBioethicsBusinessWeekMemorial Sloan-KetteringWisconsin Medical SocietyProPublicaNew York TimesMartha Rosenbergbook reviewpsychosisPartnerscommercial biasEmory UniversityUniversity of North Texas Health Science CenterAkathisiaWall Street Journal Health BlogPiesUniversity of MichiganCNS NewsNuvigilHaymarket MedicalIRINEPrimary PsychiatryPatient PrimingSentinelSourceCATIE trialJerry AvornMedtronicWyeth PharmaceuticalsLurasidoneNew York State AssemblySharfsteinEpocratesDonna BealesfibromyalgiaStratteraInvegaAmerican Journal of PsychiatryNotes from RWJames SteinSoltanSpencerReporting on HealthSternthalCouncil of Medical Specialty SocietiesNissenAmerican Psychiatric NewsNancy RappaportStosselNew YorkerTom AshbrookSenate Aging CommitteeJournal of Clinical PsychiatryPsychiatric TimessurveysNesiNemeroffMedical Marketing and MediaVerispanfree speechCE MeasureCalifornia Academy of Family PhysiciansProduct theatersKeeping Psychiatry Honest Since 2007http://carlatpsychiatry.blogspot.com/noreply@blogger.com (Daniel Carlat, M.D.)Blogger344125tag:blogger.com,1999:blog-1562387750337311798.post-5464107527573758085Fri, 06 Jan 2012 19:15:00 +00002012-01-06T14:15:19.904-05:00BMJThe British Medical Journal's great blogger Richard Lehman has published the following Ten Commandments for excellent clinical practice. These are great rules of thumb for any savvy health care practitioner--but they do require that wee bit of extra work to truly understand the statistics behind the medical literature. (Hat tip to Steve Balt, MD, for sending me the link).  The New Therapeutics: http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/_JlTj8QPJtQ/bmjs-ten-commandments-for-ideal.htmlnoreply@blogger.com (Daniel Carlat, M.D.)5http://carlatpsychiatry.blogspot.com/2012/01/bmjs-ten-commandments-for-ideal.htmltag:blogger.com,1999:blog-1562387750337311798.post-4875403343991109014Thu, 05 Jan 2012 14:18:00 +00002012-01-07T15:39:20.906-05:00super PACsColbertindustry-funded CME The current New York Times Magazine carries a fascinating and quite hilarious profile of Stephen Colbert, of the Colbert Report. Colbert is well known for his parody of a know-nothing rabidly conservative Republican commentator—but according to the article he has taken his comedy into the real world, involving himself directly in those shady instruments of electioneering known as “super PACs.” http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/0xdgOLv-5v4/on-stephen-colbert-super-pacs-and.htmlnoreply@blogger.com (Daniel Carlat, M.D.)5http://carlatpsychiatry.blogspot.com/2012/01/on-stephen-colbert-super-pacs-and.htmltag:blogger.com,1999:blog-1562387750337311798.post-4706297783861668265Wed, 04 Jan 2012 19:10:00 +00002012-01-05T09:20:55.303-05:00APADSM-VI just read Bernard Carroll's interesting post on the Health Care Renewal Blog about the latest DSM-5 brouhaha. It appears that the American Psychiatric Association has sent a "cease and desist" letter to a website critical of the DSM-5. The site was called "dsm5watch," but the APA argues that using DSM-5 in the blog title is an infringement of their trademark. The owner of the blog, Suzy Chapmanhttp://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/fvW4BwIfbi4/apa-threatens-to-sue-dsm5watch-website.htmlnoreply@blogger.com (Daniel Carlat, M.D.)9http://carlatpsychiatry.blogspot.com/2012/01/apa-threatens-to-sue-dsm5watch-website.htmltag:blogger.com,1999:blog-1562387750337311798.post-4975513622081272609Thu, 22 Dec 2011 16:54:00 +00002012-01-07T15:40:56.447-05:00Physician paymentsPhysician Payments Sunshine ActThose of us who have followed the progress of the implementation of the Physician Payment Sunshine Act have been acutely aware of one potential loophole: drug companies might try to hide payments to doctors for industry-supported CME activities. That’s because these payments are not "direct" payments to doctors, but rather indirect payments. In a 2007 op/ed piece for the New York Times, I http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/s7-SxzB5lyo/gig-is-up-sunshine-act-will-include-cme.htmlnoreply@blogger.com (Daniel Carlat, M.D.)3http://carlatpsychiatry.blogspot.com/2011/12/gig-is-up-sunshine-act-will-include-cme.htmltag:blogger.com,1999:blog-1562387750337311798.post-6767280952600034654Mon, 12 Dec 2011 21:35:00 +00002011-12-12T16:35:18.201-05:00Health AffairsThis month's issue of Health Affairs carries this fascinating article (free full text) written by a woman with MS who found out her neurologist made $300,000 in speaking and promotional activities in 3 years. The writer, Maran Wolston, also happens to be a professor of medical ethics, so she renders her personal story in a particularly thoughtful way. When she first met her neurologist 5 years http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/56eZrzS6_-k/conflict-of-interest-from-patients.htmlnoreply@blogger.com (Daniel Carlat, M.D.)8http://carlatpsychiatry.blogspot.com/2011/12/conflict-of-interest-from-patients.htmltag:blogger.com,1999:blog-1562387750337311798.post-665502192828893876Mon, 14 Nov 2011 15:15:00 +00002011-11-14T10:15:22.959-05:00CymbaltaMedscapeEli LillyPain TVSometimes in the CME field you come across something that seems so embarrassing for everybody involved that you just have to shake your head and wonder what they were thinking. So here is the link to Medscape's ACCME Accredited Category 1 CME activity called "Pain TV", supported by an "unrestricted educational grant" from Eli Lilly, manufacturer of Cymbalta, which recently won the FDA indication http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/MxUGQByNYyM/eli-lillys-pain-tv-are-they-serious.htmlnoreply@blogger.com (Daniel Carlat, M.D.)8http://carlatpsychiatry.blogspot.com/2011/11/eli-lillys-pain-tv-are-they-serious.htmltag:blogger.com,1999:blog-1562387750337311798.post-5479003649937116847Wed, 26 Oct 2011 10:14:00 +00002011-10-27T14:43:12.451-04:00FDAViibrydvilazodoneJournal of Clinical PsychiatryThe September 2011 issue of the Journal of Clinical Psychiatry created history in two ways. First, the journal published this article written by FDA staff critically reviewing the efficacy and safety data of Viibryd, a new antidepressant that the same FDA staff had just approved. Second, it was not just any journal that published the article, but the Journal of Clinical Psychiatry. Why is http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/TRIDDH--2LM/fda-slams-viibryd-better-sexual-profile.htmlnoreply@blogger.com (Daniel Carlat, M.D.)3http://carlatpsychiatry.blogspot.com/2011/10/fda-slams-viibryd-better-sexual-profile.htmltag:blogger.com,1999:blog-1562387750337311798.post-6141565061594142702Tue, 11 Oct 2011 18:01:00 +00002011-10-11T14:01:22.048-04:00BiomarkersAlzheimer's diseaseEverybody would like to find a brain scan or a blood or spinal fluid test to predict Alzheimer's disease. Such objective tests seem inherently more reliable than the clinical interview. Recently we've seen various studies identifying biomarkers for predicting who will develop Alzheimer's. The problem is that most of the studies are merely suggestive, though they are so complex that they create ahttp://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/53a2Pcg2NPY/new-study-biomarkers-are-cool-but.htmlnoreply@blogger.com (Daniel Carlat, M.D.)5http://carlatpsychiatry.blogspot.com/2011/10/new-study-biomarkers-are-cool-but.htmltag:blogger.com,1999:blog-1562387750337311798.post-3385123202714001482Fri, 09 Sep 2011 18:09:00 +00002011-09-09T14:09:46.110-04:00CME Rogue's GalleryCarlat CME InstituteWe've been beefing up the Carlat CME Institute, a website whose mission is to support excellence in non-industry-funded CME. Our latest feature is the "CME Rogue's Gallery" in which we keep a running list of the most blatantly promotional CME programs that cross our path. Currently we are spotlighting a program funded by Mylan Pharmaceuticals to increase prescription of the MAOI EMSAM, and a http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/_33vaW6YRTs/new-feature-cme-rogues-gallery.htmlnoreply@blogger.com (Daniel Carlat, M.D.)2http://carlatpsychiatry.blogspot.com/2011/09/new-feature-cme-rogues-gallery.htmltag:blogger.com,1999:blog-1562387750337311798.post-8628968169592667293Wed, 31 Aug 2011 16:01:00 +00002011-08-31T12:01:39.206-04:00<!--[if gte mso 9]> Normal 0 false false false EN-US ZH-TW X-NONE <![endif]--><!--[if gte mso 9]>http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/WBczilJcthU/dr-stahls-medical-writer-fights-back.htmlnoreply@blogger.com (Daniel Carlat, M.D.)24http://carlatpsychiatry.blogspot.com/2011/08/dr-stahls-medical-writer-fights-back.htmltag:blogger.com,1999:blog-1562387750337311798.post-6794548040286250802Sat, 27 Aug 2011 21:11:00 +00002011-08-27T17:59:51.194-04:00Stephen StahlA reader of my blog alerted me to this rambling blog post by Stephen Stahl on his NEI blog. I've pasted his article and my response below--or you can read the whole thing on his site. I’ll be curious to hear your thoughts.  Here is Dr. Stahl’s post, dated August 23 2011: "Are future psychiatric treatments doomed? Be careful what you ask for...you just might get it." Nobody likes drug companies http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/RS6pmkw9HAk/has-stephen-stahl-gone-off-deep-end-you.htmlnoreply@blogger.com (Daniel Carlat, M.D.)39http://carlatpsychiatry.blogspot.com/2011/08/has-stephen-stahl-gone-off-deep-end-you.htmltag:blogger.com,1999:blog-1562387750337311798.post-9071410632931233682Thu, 18 Aug 2011 16:01:00 +00002011-08-18T12:29:03.927-04:00(Note to readers: This will be the last non-psychiatric post on this blog--from now on, all medical education-related articles will be posted on the new Carlat CME Blog.) In a rather embarrassing attempt to raise revenues, a restaurant in Syracuse, New York, is now explicitly marketing itself as a purveyor of drug company dinners. Francesca's Cucina, "Located in the heart of Syracuse's Littlehttp://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/mnsb37XLY0s/syracuse-restaurant-becomes.htmlnoreply@blogger.com (Daniel Carlat, M.D.)8http://carlatpsychiatry.blogspot.com/2011/08/syracuse-restaurant-becomes.htmltag:blogger.com,1999:blog-1562387750337311798.post-2911773752692490135Mon, 15 Aug 2011 19:10:00 +00002011-08-15T15:10:54.609-04:00Ridge DiagnosticsBiomarkersThis month's Psychiatric Times has an interesting article (requires a subscription) about putative blood tests for diagnosing schizophrenia and depression. Because most of my patients have either depression or anxiety, I skipped to the section on a new depression blood test marketed by Ridge Diagnostics. Called the "MDDScore," the test measures 10 biomarkers, including cortisol, brain-derived http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/IgAd_nDKDL0/blood-test-for-depression-really.htmlnoreply@blogger.com (Daniel Carlat, M.D.)26http://carlatpsychiatry.blogspot.com/2011/08/blood-test-for-depression-really.htmltag:blogger.com,1999:blog-1562387750337311798.post-485302447495203990Tue, 05 Jul 2011 20:19:00 +00002011-07-05T16:19:30.596-04:00CS2dayPfizerChantixBy now most of you have heard about this recent study linking the use of Pfizer's anti-smoking drug Chantix with a small increase in heart attacks and arrhythmias. The meta-analysis of 14 double-blind controlled trials indicates that in patients without a history of heart disease, Chantix increases the rate of serious cardiac events from 0.82% of those assigned to placebo to 1.06% of those on http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/IsYO7GyYXW4/biggest-chantix-news-pfizers-123.htmlnoreply@blogger.com (Daniel Carlat, M.D.)10http://carlatpsychiatry.blogspot.com/2011/07/biggest-chantix-news-pfizers-123.htmltag:blogger.com,1999:blog-1562387750337311798.post-2595896516355153176Fri, 24 Jun 2011 14:12:00 +00002011-06-24T10:12:29.057-04:00Thomas SullivanMedical Marketing and MediaCEJAPolicy and Medicine<!--[if gte mso 9]> Normal 0 false false false EN-US ZH-TW X-NONE MicrosoftInternetExplorer4 <![endif]--><!--[if gte mso 9]>http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/gMpiYrIDNQ4/apres-le-deluge-ceja-spin-cycle-begins.htmlnoreply@blogger.com (Daniel Carlat, M.D.)14http://carlatpsychiatry.blogspot.com/2011/06/apres-le-deluge-ceja-spin-cycle-begins.htmltag:blogger.com,1999:blog-1562387750337311798.post-4889573926914705068Tue, 21 Jun 2011 20:42:00 +00002011-06-21T17:51:01.464-04:00CEJAAMASomething huge happened yesterday at the American Medical Association House of Delegates meeting in Chicago. Although the meaning of what happened will be spun throughout the blogosphere, twittersphere, and schmuckosphere, the bottom line is that the AMA just voted most commercial funding of CME out of existence. Specifically, the delegates voted to approve a report of the AMA ethics committee http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/dvUNB7Fa2GU/ama-votes-to-discourage-commercial.htmlnoreply@blogger.com (Daniel Carlat, M.D.)9http://carlatpsychiatry.blogspot.com/2011/06/ama-votes-to-discourage-commercial.htmltag:blogger.com,1999:blog-1562387750337311798.post-6523070533106727679Tue, 21 Jun 2011 17:59:00 +00002011-06-21T13:59:42.917-04:00The July 14, 2011 issue of The New York Review of Books includes the second of a two-part review of several new books on the topic of psychiatry, including my book Unhinged. Review author Marcia Angell, Senior Lecturer in Social Medicine at Harvard Medical School and former Editor in Chief of The New England Journal of Medicine, calls Unhinged “absorbing” in her article “The Illusions of http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/C2ai2pH96G0/unhinged-in-new-york-review-of-books.htmlnoreply@blogger.com (Daniel Carlat, M.D.)6http://carlatpsychiatry.blogspot.com/2011/06/unhinged-in-new-york-review-of-books.htmltag:blogger.com,1999:blog-1562387750337311798.post-1199634076044555165Wed, 25 May 2011 16:19:00 +00002011-05-25T12:19:56.407-04:00by Steve Balt In keeping with the religious notion of reincarnation, apparently some drugs are destined to be reborn, redesigned, and re-packaged for brand new indications.  I've written about Contrave and Silenor for instance—two drugs with generic counterparts that have been re-tweaked and renamed for newer (and larger) markets. In early April, the FDA granted its approval to yet another "new"http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/qP6a5hARYp4/horizant-second-coming-of-gabapentin.htmlnoreply@blogger.com (Daniel Carlat, M.D.)36http://carlatpsychiatry.blogspot.com/2011/05/horizant-second-coming-of-gabapentin.htmltag:blogger.com,1999:blog-1562387750337311798.post-6411793466675574295Mon, 16 May 2011 11:35:00 +00002011-05-16T16:01:43.781-04:00QuantiaMDThere are a number of new and rapidly growing physician social networking sites, and two of the largest are Sermo and QuantiaMD. They both offer tempting packages of free information to doctors, including CME. When stuff is free to you, someone else is paying for it. That "someone" has a stake in the content, and the art of operating an ethical educational website hinges on creating a good http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/eC9Q2Syeskc/review-of-quantiamd-good-content-murky.htmlnoreply@blogger.com (Daniel Carlat, M.D.)10http://carlatpsychiatry.blogspot.com/2011/05/review-of-quantiamd-good-content-murky.htmltag:blogger.com,1999:blog-1562387750337311798.post-7940649544050168381Fri, 13 May 2011 21:22:00 +00002011-05-13T22:23:09.260-04:00Makers of atypical antipsychotics are desperately trying to differentiate their products from their competitors. This explains the deceptive insert from Vanda Pharmaceuticals that was bagged with the latest version of the APA's newspaper, Psychiatric News. The insert is a 5 X 8 inch 4 page booklet. The front cover is below: Evidently appealing to the scratch-ticket set among psychiatrists,http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/F-7XNyIks00/apa-joins-vanda-in-running-misleading.htmlnoreply@blogger.com (Daniel Carlat, M.D.)5http://carlatpsychiatry.blogspot.com/2011/05/apa-joins-vanda-in-running-misleading.htmltag:blogger.com,1999:blog-1562387750337311798.post-7457108214210712521Fri, 06 May 2011 14:55:00 +00002011-05-06T10:59:23.833-04:00Heart Rhythm SocietyProPublicaIn a fascinating series of articles released yesterday, ProPublica details how a heretofore obscure medical organization, the Heart Rhythm Society, pulls drug and device company cash in hand over fist. You'll find the main article here, along with links to several companion pieces, my favorite being this devilishly fun interactive piece in which you can click on graphics of cardiologists http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/fQXjkvL0jf8/lub-dub-lub-lub-lub-dubka-ching.htmlnoreply@blogger.com (Daniel Carlat, M.D.)3http://carlatpsychiatry.blogspot.com/2011/05/lub-dub-lub-lub-lub-dubka-ching.htmltag:blogger.com,1999:blog-1562387750337311798.post-6855105845713305571Wed, 04 May 2011 17:09:00 +00002011-05-04T13:13:05.952-04:00ACCMEIn an absolutely perplexing move, Dr. Murray Kopelow and the ACCME are proposing a revision to their Standards for Commercial Support that will undermine those standards. Currently, when an education company solicits money from industry to underwrite a course for doctors, they must disclose this inherent conflict of interest, and they often do so by printing the company's logo somewhere. As an http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/CvNRLmZWpIo/accme-seeks-to-hide-drug-company.htmlnoreply@blogger.com (Daniel Carlat, M.D.)8http://carlatpsychiatry.blogspot.com/2011/05/accme-seeks-to-hide-drug-company.htmltag:blogger.com,1999:blog-1562387750337311798.post-4906825494403592295Wed, 27 Apr 2011 19:43:00 +00002011-04-27T15:43:24.682-04:00<!--[if gte mso 9]> Your User Name 12.00 <![endif]--><!--[if gte mso 9]> Normal 0 false false false EN-US ZH-TW X-NONE MicrosoftInternetExplorer4 <![endif]--><!--[if gte mso 9]>http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/YJLHP72TP7U/house-votes-to-repeal-physicians-oyster.htmlnoreply@blogger.com (Daniel Carlat, M.D.)4http://carlatpsychiatry.blogspot.com/2011/04/house-votes-to-repeal-physicians-oyster.htmltag:blogger.com,1999:blog-1562387750337311798.post-61169408311435084Sun, 17 Apr 2011 14:53:00 +00002011-04-17T10:53:36.995-04:00MedscapeEli LillyPerformance Improvement CME has become all the rage in the world of continuing medical education. Otherwise known as PI CME, it is being touted by the AMA as the next big thing in medical education. You can read an AMA white paper about it here. Not all medical specialty organizations actually require that physicians complete PI CME, but they are moving toward this. The American Board of http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/RaxN_Txc-bs/performance-improvement-cme-brought-to.htmlnoreply@blogger.com (Daniel Carlat, M.D.)7http://carlatpsychiatry.blogspot.com/2011/04/performance-improvement-cme-brought-to.htmltag:blogger.com,1999:blog-1562387750337311798.post-6951764012963414144Mon, 11 Apr 2011 20:47:00 +00002011-04-11T16:47:51.672-04:00Alan SchatzbergNemeroffA new piece of evidence has been unearthed by Phyllis Vine of MIWatch that the Nemeroff/Schatzberg textbook was indeed ghostwritten by STI, Scientific Therapeutics Information. Somehow, Vine was able to unearth STI's "portfolio" of publications, even though the company has since removed the incriminating pages. I suppose APA might still hold to its guns, presumably by arguing that STI did no http://feedproxy.google.com/~r/TheCarlatPsychiatryBlog/~3/oKgyzTah2XY/new-smoking-gun-in-apa-textbook-fiasco.htmlnoreply@blogger.com (Daniel Carlat, M.D.)5http://carlatpsychiatry.blogspot.com/2011/04/new-smoking-gun-in-apa-textbook-fiasco.html